By Nick Johnson (Apyx) In 2020 Shareholder News, 2025 Shareholder News, RenuvionPosted March 25, 2025RENUVION WINS 2025 NEWBEAUTY AWARD FOR “BEST MINIMALLY INVASIVE SKIN TIGHTENER” READ MORE
By apyxmedical In 2020 Shareholder News, Case Study, J-Plasma, RenuvionPosted November 23, 2020APYX MEDICAL CORPORATION ANNOUNCES APPROVAL FROM FDA TO BEGIN PHASE II OF U.S. IDE STUDY READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted November 9, 2020APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS READ MORE
By apyxmedical In 2020 Shareholder News, Case Study, J-Plasma, RenuvionPosted November 9, 2020APYX MEDICAL CORPORATION ANNOUNCES UPDATES ON U.S. IDE CLINICAL STUDIES READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted October 20, 2020APYX MEDICAL CORPORATION ANNOUNCES TWO PEER-REVIEWED CLINICAL PUBLICATIONS EVALUATING RENUVION’S HELIUM PLASMA TECHNOLOGY READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted October 1, 2020APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS ON NOVEMBER 9, 2020 READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted August 31, 2020APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted August 7, 2020APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted June 25, 2020APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS ON AUGUST 10, 2020 READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted June 22, 2020APYX MEDICAL CORPORATION ANNOUNCES REGULATORY CLEARANCE TO MARKET AND SELL ITS HELIUM PLASMA TECHNOLOGY PRODUCTS IN FIVE NEW COUNTRIES READ MORE
